- Home
- BNZI vs SNGX Comparison
BNZI vs SNGX Comparison
Compare BNZI & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- SNGX
- Stock Information
- Founded
- BNZI 2016
- SNGX 1987
- Country
- BNZI United States
- SNGX United States
- Employees
- BNZI N/A
- SNGX N/A
- Industry
- BNZI
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- SNGX Health Care
- Exchange
- BNZI Nasdaq
- SNGX Nasdaq
- Market Cap
- BNZI 11.5M
- SNGX 10.1M
- IPO Year
- BNZI N/A
- SNGX 1987
- Fundamental
- Price
- BNZI $2.46
- SNGX $2.86
- Analyst Decision
- BNZI Strong Buy
- SNGX Strong Buy
- Analyst Count
- BNZI 1
- SNGX 1
- Target Price
- BNZI $240.00
- SNGX $6.00
- AVG Volume (30 Days)
- BNZI 402.9K
- SNGX 10.2M
- Earning Date
- BNZI 08-14-2025
- SNGX 11-07-2025
- Dividend Yield
- BNZI N/A
- SNGX N/A
- EPS Growth
- BNZI N/A
- SNGX N/A
- EPS
- BNZI N/A
- SNGX N/A
- Revenue
- BNZI $9,021,543.00
- SNGX N/A
- Revenue This Year
- BNZI $337.60
- SNGX N/A
- Revenue Next Year
- BNZI $91.81
- SNGX N/A
- P/E Ratio
- BNZI N/A
- SNGX N/A
- Revenue Growth
- BNZI 107.94
- SNGX N/A
- 52 Week Low
- BNZI $2.35
- SNGX $1.09
- 52 Week High
- BNZI $112.00
- SNGX $6.23
- Technical
- Relative Strength Index (RSI)
- BNZI 32.88
- SNGX 49.77
- Support Level
- BNZI $3.06
- SNGX $2.72
- Resistance Level
- BNZI $3.43
- SNGX $3.11
- Average True Range (ATR)
- BNZI 0.29
- SNGX 0.49
- MACD
- BNZI -0.01
- SNGX -0.10
- Stochastic Oscillator
- BNZI 7.19
- SNGX 3.99
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).